- Home
- ISPC vs PALI Comparison
ISPC vs PALI Comparison
Compare ISPC & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- PALI
- Stock Information
- Founded
- ISPC 2009
- PALI 1996
- Country
- ISPC United States
- PALI United States
- Employees
- ISPC N/A
- PALI N/A
- Industry
- ISPC Precision Instruments
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPC Health Care
- PALI Health Care
- Exchange
- ISPC Nasdaq
- PALI Nasdaq
- Market Cap
- ISPC 3.1M
- PALI 3.7M
- IPO Year
- ISPC 2021
- PALI N/A
- Fundamental
- Price
- ISPC $0.99
- PALI $0.73
- Analyst Decision
- ISPC
- PALI Strong Buy
- Analyst Count
- ISPC 0
- PALI 2
- Target Price
- ISPC N/A
- PALI $12.00
- AVG Volume (30 Days)
- ISPC 46.8K
- PALI 424.6K
- Earning Date
- ISPC 08-05-2025
- PALI 08-11-2025
- Dividend Yield
- ISPC N/A
- PALI N/A
- EPS Growth
- ISPC N/A
- PALI N/A
- EPS
- ISPC N/A
- PALI N/A
- Revenue
- ISPC $8,058,631.00
- PALI N/A
- Revenue This Year
- ISPC $35.93
- PALI N/A
- Revenue Next Year
- ISPC N/A
- PALI N/A
- P/E Ratio
- ISPC N/A
- PALI N/A
- Revenue Growth
- ISPC N/A
- PALI N/A
- 52 Week Low
- ISPC $0.86
- PALI $0.60
- 52 Week High
- ISPC $11.80
- PALI $4.89
- Technical
- Relative Strength Index (RSI)
- ISPC 43.82
- PALI 53.83
- Support Level
- ISPC $0.90
- PALI $0.66
- Resistance Level
- ISPC $1.03
- PALI $0.77
- Average True Range (ATR)
- ISPC 0.07
- PALI 0.04
- MACD
- ISPC -0.00
- PALI 0.01
- Stochastic Oscillator
- ISPC 36.03
- PALI 76.29
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.